FONAR Corporation
HealthcareNASDAQ:FONR · NASDAQ Capital Market
+$0.00 today
Vol 0.00M · Avg 0.08M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
4.8%
avg 14.8%
ROIC
4.4%
avg 13.0%
ROA
3.8%
avg 10.4%
Analysis
ROE is currently the strongest return metric at 4.8% versus its period average of 14.8%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Luciano Bonanni | Chief Operating Officer, Executive Vice President & Acting Principal Financial Officer | $498,241.00 | — | 71 | $0.00 | <0.01% |
John Collins | General Counsel & Acting Secretary | $437,155.00 | — | 45 | — | — |
Timothy R. Damadian | Chairman, President, Chief Executive Officer & Treasurer | $295,000.00 | — | 62 | $0.00 | <0.01% |
Daniel Culver | Director of Communications | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
6
$10.56M
Sells
0
$0.00
Net Sentiment
+$10.56M
Net buying
Most Active
shane hilary
6 transactions
Analysis
Insiders reported 6 buys worth $10.56M and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $10.56M. shane hilary was the most active insider with 6 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +28.9% | N/A — |
| Revenue | N/A | N/A | +20.5% | N/A — |
| Net Income | N/A | N/A | +30.7% | N/A — |
| EBIT | N/A | N/A | +21.4% | N/A — |
Analysis
Recent growth has been strongest in Net Income at +30.7% over three years.
Competitors
Peer companies in the same sector
Artiva Biotherapeutics, Inc.
NASDAQ:ARTV
$211.08M
Apyx Medical Corporation
NASDAQ:APYX
$196.39M
Edap Tms S.a.
EDAP
$178.23M
Quipt Home Medical Corp.
QIPT
$162.30M
InflaRx N.V.
NASDAQ:IFRX
$115.57M
Hyperfine, Inc.
NASDAQ:HYPR
$114.53M
AVITA Medical, Inc.
NASDAQ:RCEL
$97.14M
Vivani Medical, Inc.
NASDAQ:VANI
$64.99M
Pulmonx Corporation
NASDAQ:LUNG
$57.86M
InspireMD, Inc.
NSPR
$34.19M
Who manages FONR?
FONAR Corporation (FONR) lists 4 active executives. The top listed executive is John Collins, General Counsel & Acting Secretary.
Are FONR insiders buying or selling?
Recent insider activity shows net buying of $10.44M.
Explore More
Continue the stock analysis
Jump to another research area for this company.